Form 8-K - Current report:
SEC Accession No. 0001493152-26-031328
Filing Date
2026-06-30
Accepted
2026-06-30 17:19:32
Documents
11
Period of Report
2026-06-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 65882
  Complete submission text file 0001493152-26-031328.txt   234910

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE kapa-20260629.xsd EX-101.SCH 3026
3 XBRL LABEL FILE kapa-20260629_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE kapa-20260629_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3315
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42275 | Film No.: 261141633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)